The new year is off to a disastrous start for the All Ordinaries Index (ASX: XAO) and most of the shares that call it home.
Despite posting a strong start to Tuesday's session – it jumped as high as 0.47% in early trade – the benchmark index tumbled to a two-month low this afternoon.
Right now, the All Ordinaries is down 1.62% at 7,104.7 points.
Fortunately, though, not all its constituents are suffering. We've rounded up three that are posting gains of as much as 7%. Let's take a look.
3 All Ordinaries shares posting whopping gains
The first All Ordinaries share defying today's tumble is Airtasker Ltd (ASX: ART). Stock in the online marketplace for services is leaping 2.9% to trade at 35.5 cents right now despite the company's silence.
Sadly, however, today's gain hasn't proven enough to boost the embattled share back into the long-term green. It's fallen 75% since it floated on the ASX in March 2021.
Next up is media and entertainment company HT&E Ltd (ASX: HT1). The All Ordinaries share is roaring 3.63% higher to swap hands for $1 apiece. Its gain comes on news of a major divestment.
The company today revealed it's agreed to sell its 25% stake in Soprano Design to Potentia Capital for around $66.3 million in cash.
If the name Potentia rings any bells, it's likely because it's the private equity firm that recently put in so-far-unsuccessful bids for both Tyro Payments Ltd (ASX: TYR) and Nitro Software Ltd (ASX: NTO).
Finally, the Neuren Pharmaceuticals Ltd (ASX: NEU) share price is rocketing 7.67% right now to trade at $8.56.
That's despite no news having been released by the All Ordinaries biopharmaceutical share.
Today's gain included, the stock is just 2.8% lower than the 15-year high it posted in November.
